Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1991 | 09-1991 | 06-1991 | 03-1991 | 12-1990 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,793 | N/A | N/A | N/A | -8,674 |
| Depreciation Amortization | 486 | N/A | N/A | N/A | 284 |
| Other Working Capital | -274 | N/A | N/A | N/A | 982 |
| Other Operating Activity | 1,615 | 0 | 0 | 0 | 1,552 |
| Operating Cash Flow | $-11,966 | $N/A | $N/A | $N/A | $-5,856 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -825 | N/A | N/A | N/A | -841 |
| Net Acquisitions | -53 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -10,837 | 0 | 0 | 0 | -1,695 |
| Investing Cash Flow | $-11,715 | $N/A | $N/A | $N/A | $-2,536 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 21,078 | 0 | 0 | 0 | 11,607 |
| Financing Cash Flow | $21,078 | $N/A | $N/A | $N/A | $11,607 |
| Beginning Cash Position | 6,342 | N/A | N/A | N/A | 3,426 |
| End Cash Position | 3,740 | N/A | N/A | N/A | 6,640 |
| Net Cash Flow | $-2,602 | $N/A | $N/A | $N/A | $3,215 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,966 | N/A | N/A | N/A | -5,856 |
| Free Cash Flow | -11,966 | 0 | 0 | 0 | -5,856 |